Animal models for sars

Advances in Experimental Medicine and Biology

Volumn 581, Issue , 2006, Pages 463-471

  Roberts, Anjeanette ^a   Subbarao, Kanta ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934443997     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33012-9_83     Document Type: Conference Paper

References (26)

1. K. Subbarao, J. McAuliffe, et al., Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice, J. Virol. 78, 3572-3577 (2004).
2. D. E. Wentworth, L. Gillim-Ross, N. Espina, and K. A. Bernard, Mice susceptible to SARS coronavirus, Emerg. Infect. Dis. 10, 1293-1296 (2004).
3. W. G. Glass, K. Subbarao, B. Murphy, and P. M. Murphy, Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice, J. Immunol. 173, 4030-4039 (2004).
4. R. J. Hogan, G. Gao, et al., Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1, J, Virol, 78, 11416-11421 (2004).
5. A. Roberts, C. Paddock, L. Vogel, E. Butler, S. Zaki, and K. Subbarao, Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans, J. Virol. 79, 5833-5838 (2005).
6. H. Bisht, A. Roberts, L. Vogel, A. Bukreyev, P. L. Collins, B. R. Murphy, K. Subbarao, and B. Moss, Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice, Proc. Natl. Acad. Sci. USA 101, 6641-6646 (2004).
7. H. Bisht, A. Roberts, L. Vogel, K. Subbarao, and B. Moss, Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein, Virology 334, 160-165 (2005).
8. E. Traggiai, S. Becker, et al., Rapid and efficient isolation of human monoclonal antibodies neutralizing SARS coronavirus from human memory B cells, Nat. Med. 10, 871-875 (2003).
9. Z. Y. Yang, W. P. Kong, Y. Huang, A. Roberts, B. R. Murphy, K. Subbarao, and G. J. Nabel, A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice, Nature 428, 561-564 (2004).
10. J. Sui, W. Li, et al., Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants, J. Virol. 79, 5900-5906 (2005).
11. T. C. Greenough, G. J. Babcock, et al., Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice, J. Infect. Dis. 191, 507-514 (2005).
12. S. U. Kapadia, J. K. Rose, E. Lamirande, L. Vogel, K. Subbarao, and A. Roberts, Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine, Virology 340: 174-182 (2005).
13. A. Roberts, L. Vogel, J. Guarner, N. Hayes, B. Murphy, S. Zaki, and K. Subbarao, Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters, J. Virol. 79, 503-511 (2005).
14. A. Roberts, W. D. Thomas, J. Guarner, E. W. Lamirande, G. J. Babcock, et al., Therapy with a severe acute respiratory. Syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and virus burden in golden syrian hamsters, J. Infect. Dis. 193, 685-692(2006).
15. B. E. E. Martina, B. L. Haagmans, et al., SARS virus infection of cats and ferrets, Nature 425(915 (2003).
16. J. ter Meulen, A. B. Bakker, et al., Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets, Lancet 363(9427), 2139-41 (2004).
17. B. E. Martina, B. L. Haagmans, et al., Virology: SARS virus infection of cats and ferrets, Nature 425, 915 (2003).
18. D. Wu, C. Tu, et al., Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates, J. Virol. 79, 2620-2625 (2005).
19. Y. Guan, B. J. Zheng, et al., Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China, Science 302, 276-278 (2003).
20. T. Rowe, G. Gao, et al., Macaque model for severe acute respiratory syndrome, J. Virol. 78, 11401-11404 (2004).
21. J. McAuliffe, L. Vogel, et al., Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys, Virology 330, 8-15 (2004).
22. R. A. Fouchier, T. Kuiken, et al., Aetiology: Koch's postulates fulfilled for SARS virus, Nature 423, 240 (2003).
23. T. Kuiken, R. A. Fouchier, et al., Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome, Lancet 362, 263-270 (2003).
24. B. L. Haagmans, T. Kuiken, et al., Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques, Nat. Med. 10, 290-293 (2004).
25. C. Qin, J. Wang, et al., An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus, J. Pathol. 206, 251-259 (2005).
26. T. C. Greenough, A. Carville, J. Coderre, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, and K. Mansfield, Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus, Am. J. Pathol. 167, 455-463 (2005).